5LH0.F Guard Therapeutics International AB (publ)

Healthcare Drug Manufacturers - General Frankfurt Exchange
0.0689 EUR
Close of Nov 11, 2026
0.0001 0.1292
Market cap
EUR 3.07M
P/E
-
P/B
0.68x
ROE
-69.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is 5LH0.F undervalued?

Graham number

The Graham number of Guard Therapeutics International AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guard Therapeutics International AB (publ) fundamental analysis

No fundamental analysis for Guard Therapeutics International AB (publ) yet.

Guard Therapeutics International AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guard Therapeutics International AB (publ)

Disruptive Pharma AB (publ) operates as a pharmaceutical technology company in Sweden. The company develops and commercializes Formulite, a patented and clinically evaluated platform technology for oral drug formulation and drug product development. The company is based in Stockholm, Sweden.

Full company profile